A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity

Abroad (travel likely)RecruitingPHASE1

Conditions

Overweight · Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Profil Institut für Stoffwechselforschung, Neuss, Germany
Study coordinator · 4921314018180
Contact: Principal Investigator (Patrick Fischer)
CTC GoCo, Mölndal, Sweden
Study coordinator · 46317001180
Contact: Principal Investigator (Kaj Stenlöf)

Study leads

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Overweight · Obesity

IsraelRecruitingPHASE3

Birmingham, United States · Phoenix, United States

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Obesity & Overweight

Abroad (travel likely)RecruitingPHASE3

Shanghai, China

Predicting Difficult Intubation in Bariatric Surgery: Comparison of El Ganzouri Risk Index and Airway Ultrasound

Obesity & Overweight · Obesity Difficult Airway Airway Management · Obesity (Disorder)

Abroad (travel likely)Recruiting

Antalya, Turkey (Türkiye)

Ultrasound Assessment of Tongue Characteristics in Children and Adolescents With Obesity

Obesity & Overweight · Pediatric Obesity · Obstructive Sleep Apnea (OSA)

Abroad (travel likely)Recruiting

Brussels, Belgium · De Haan, Belgium